...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: & on this AGM day we start off the day by dropping over 30%

FuzzyJr and RVXOldtimer, thanks.  I see the 40 cent quote at TD but TD also shows the last price at 25 cents.  I guess the .40 is old. 

Share
New Message
Please login to post a reply